We can't beat cancer alone. We work closely with partners to progress research and turn more discoveries into effective tools, treatments and diagnostics so that cancer patients benefit from research.
We partner in several ways, including through licensing, startups, collaborations, and forming drug discovery alliances. Our partners include academic institutions, pharmaceutical and biotechnology companies, investors, and other medical research charities.
Together with our partners, we push the boundaries of science to deliver innovative breakthroughs and address cancer patients' unmet needs.
Pharmaceutical and biotechnology companies
We continuously seek new and innovative partnerships. We offer unique opportunities to pharmaceutical and biotechnology partners who are looking to get involved in new, cutting-edge discoveries.
We partner with researchers to develop their research to its full potential. We support researchers to translate their work through our funding, capabilities, and expertise, tailored to suit their needs.
How we partner with researchers
We spot and build unique investment opportunities. We partner with investors to accelerate the development of world-class oncology focused opportunities across therapeutics, diagnostics, medtech and AI sectors.